[ad_1]
The EU Pharmacovigilance Authority has indicated that this decision could be made before 29 January.
“The EEA has received a conditional marketing authorization for COVID-19, developed by AstraZeneca and the University of Oxford,” the Amsterdam-based agency said in a statement.
The European Medicines Agency has already approved two COVID-19 vaccines, developed by Pfizer and BioNTech, in addition to Moderna.
The EEA has indicated that AstraZeneca will evaluate the product using an accelerated procedure.
“The conclusion of the marketing authorization could be reached on January 29 … provided that the data provided on the quality, safety and efficacy of the vaccine are sufficiently reliable and complete,” the agency said in a statement.
The EU and EEA have come under pressure to speed up the approval of new vaccines, and the coronavirus pandemic has cost more than 620,000 people in Europe. human lives.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
